Danazol: molecular, endocrine, and clinical pharmacology.
article
OA: closed
CC0
⤵ 12 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This paper explores the molecular, endocrine, and clinical pharmacology of danazol, a synthetic steroid used to treat conditions like endometriosis and fibrocystic breast disease.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
Cited by (12)
- Androgen Signaling in Uterine Diseases: New Insights and New Targets 2022
- Adenomyosis: a systematic review of medical treatment 2016
- History of Endometriosis: A 20th‐Century Disease 2011
- Diagnosis and treatment of endometriosis 2003
- Endometriosis: novel etiopathogenetic concepts and clinical perspectives 2002
- A Benefit-Risk Assessment of Medical Treatment for Uterine Leiomyomas 2002
- Medical management of endometriosis and infertility 2000
- Danazol relieves refractory pruritus associated with myeloproliferative disorders and other diseases 1996
- [<sup>3</sup>H]Dexamethasone Binding Activity in Liver Microsomes is Modulated Differently by 17 α‐Alkylated Androgens and Testosterone<i>in vivo</i> 1995
- Danazol for urinary incontinence in tropical spastic paraparesis 1992
- Danazol in the Treatment of Menorrhagia: The Effect of a 1 Month Induction Dose (200 mg) and 2 Month's Maintenance Therapy (200 mg, 100 mg, 50 mg or placebo) 1992
- Depot leuprolide versus danazol in treatment of women with symptomatic endometriosis 1992
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-05-10T10:20:29.515715+00:00
- pubmed
- last seen: 2026-05-13T22:12:15.619952+00:00
License: CC0
· commercial use OK